Plain-English translation of NCT06937203 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new experimental medication called to see if it can help adults with obesity lose weight. Researchers want to understand whether the medication is safe, how the body processes it, and how well it works. Some participants will receive the medication alone, while others may receive it combined with another weight loss drug called tirzepatide, and some will receive a placebo (a dummy treatment) to compare results.
Current weight loss treatments don't work for everyone, and many people struggle to keep weight off with diet and exercise alone. This trial is exploring whether this new medication could offer a safe and effective option for people living with obesity, including those who also have type 2 diabetes.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times over about 8–9 months. At some visits, you will receive doses of the medication (or placebo) by injection on specific days. If you are in certain groups, you may also receive weekly injections of tirzepatide starting a few weeks into the study. Throughout the study, researchers will check your health with blood tests, physical exams, and other routine tests to monitor for any side effects and to see how the medication is working.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Australia
New Zealand